[HTML][HTML] What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?
P Chmiel, P Rutkowski, M Spałek… - … Treatment Options in …, 2024 - Springer
Soft tissue sarcomas (STS) are a rare and diverse group of malignancies that account for
approximately 1% of all adult cancers [1]. In Europe, the estimated incidence is 4-5 cases …
approximately 1% of all adult cancers [1]. In Europe, the estimated incidence is 4-5 cases …
What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?
P Chmiel, P Rutkowski, M Spałek… - … Treatment Options in …, 2024 - europepmc.org
Soft tissue sarcomas (STS) are rare tumours of mesenchymal origin, most commonly
occurring in the extremity but also in the retroperitoneum. The curative treatment for STS is …
occurring in the extremity but also in the retroperitoneum. The curative treatment for STS is …
What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?
P Chmiel, P Rutkowski, M Spałek… - … treatment options in … - pubmed.ncbi.nlm.nih.gov
Soft tissue sarcomas (STS) are rare tumours of mesenchymal origin, most commonly
occurring in the extremity but also in the retroperitoneum. The curative treatment for STS is …
occurring in the extremity but also in the retroperitoneum. The curative treatment for STS is …